Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec;299(12):105399.
doi: 10.1016/j.jbc.2023.105399. Epub 2023 Oct 28.

Mitochondrial hydrogen peroxide production by pyruvate dehydrogenase and α-ketoglutarate dehydrogenase in oxidative eustress and oxidative distress

Affiliations
Review

Mitochondrial hydrogen peroxide production by pyruvate dehydrogenase and α-ketoglutarate dehydrogenase in oxidative eustress and oxidative distress

Olivia Chalifoux et al. J Biol Chem. 2023 Dec.

Abstract

Pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase (KGDH) are vital entry points for monosaccharides and amino acids into the Krebs cycle and thus integral for mitochondrial bioenergetics. Both complexes produce mitochondrial hydrogen peroxide (mH2O2) and are deactivated by electrophiles. Here, we provide an update on the role of PDH and KGDH in mitochondrial redox balance and their function in facilitating metabolic reprogramming for the propagation of oxidative eustress signals in hepatocytes and how defects in these pathways can cause liver diseases. PDH and KGDH are known to account for ∼45% of the total mH2O2 formed by mitochondria and display rates of production several-fold higher than the canonical source complex I. This mH2O2 can also be formed by reverse electron transfer (RET) in vivo, which has been linked to metabolic dysfunctions that occur in pathogenesis. However, the controlled emission of mH2O2 from PDH and KGDH has been proposed to be fundamental for oxidative eustress signal propagation in several cellular contexts. Modification of PDH and KGDH with protein S-glutathionylation (PSSG) and S-nitrosylation (PSNO) adducts serves as a feedback inhibitor for mH2O2 production in response to glutathione (GSH) pool oxidation. PSSG and PSNO adduct formation also reprogram the Krebs cycle to generate metabolites vital for interorganelle and intercellular signaling. Defects in the redox modification of PDH and KGDH cause the over generation of mH2O2, resulting in oxidative distress and metabolic dysfunction-associated fatty liver disease (MAFLD). In aggregate, PDH and KGDH are essential platforms for emitting and receiving oxidative eustress signals.

Keywords: fatty liver disease; hydrogen peroxide; mitochondria; oxidative distress; oxidative eustress; pyruvate dehydrogenase; redox signaling; α-ketoglutarate dehydrogenase.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Figure 1
Figure 1
The entry of carbon into the Krebs cycle through PDH and KGDH, the catalytic cycle of the α-ketoacid dehydrogenases, and the sites for redox regulation and mH2O2generation.A, the entry of monosaccharides (glucose) and amino acids into mitochondria and the Krebs cycle through pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase (KGDH). Acetyl-CoA and succinyl-CoA formed by PDH and KGDH are oxidized further by the rotation of the Krebs cycle, producing the electron carrier NADH which is metabolized by the electron transport chain (ETC) to generate ATP by oxidative phosphorylation (OxPhos). PDH and KGDH catalyze high energy reactions in the Krebs cycle and are thus important sites for allosteric activation and deactivation (denoted by red × or green triangle). B, the catalytic pathway for the keto acid dehydrogenases using KGDH as an example. α-ketoglutarate is decarboxylated on the C1 position (in blue) by α-ketoglutarate decarboxylase (E1), transferring the succinyl group to thiamine pyrophosphate (TPP). The dihydrolipoamide succinyltransferase (or acyltransferase: E2, DLAT) catalyzes the formation of a high-energy thioester bond via the transfer of the succinyl moiety from TPP to coenzyme A (CoASH). The dihydrolipoamide is then oxidized by the dehydrogenase activity of the E3 subunit (dihydrolipoamide dehydrogenase or DLD), reducing FAD to FADH2 and then producing NADH. Electrons leak from the FAD through side reactions that generate semiflavin radicals, flavin hydroperoxides, and oxy-flavin radicals, which form mH2O2. Note that the FAD can generate both mitochondrial superoxide (mO2•−) and mitochondrial (mH2O2), reactions that depend on the redox state of the flavin and its interactions with molecular oxygen (O2). The mO2•− is dismutated to mH2O2 by superoxide dismutase (SOD; intermembrane space = SOD1, matrix = SOD2). The E2 dihydrolipoamide is a target for redox modifications by mH2O2 and various electrophiles and soft acid metals (e.g., arsenic) which block the activity of the enzyme but also inhibit mH2O2 generation. The figure was generated with Biorender Software (Agreement Number: NR25TFIEU4).
Figure 2
Figure 2
Oxidative eustress and oxidative distress and the role of pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase (KGDH) in supplying mitochondrial (mH2O2) for optimal liver health. Spatio-temporal control over mH2O2 generation triggers oxidative eustress pathways (left) which activate proliferation, adaptation, growth, and repair cascades required for the restoration of normal hepatic function and maintaining optimal liver health. The mH2O2 levels oscillate in the 1 to 100 nM range, which is achieved, in part, through the regulation of its production through activation and inhibition of PDH and KGDH. Defects in the regulation of mH2O2 generation by PDH and KGDH result in its sustained overproduction. This sustained overgeneration of mH2O2 is due to factors that promote mitochondrial dysfunction (e.g., toxins or poor nutrition). This promotes mH2O2 accumulation, triggering oxidative distress. This oxidative distress (right) is characterized by defective oxidative eustress signals, over-oxidation of antioxidant defenses, and cell damage and death. These effects result in inflammation, hepatic ballooning, and metabolic dysfunction causing irreversible liver damage (cirrhosis) and the development of hepatocellular carcinoma. Note that the early stages of MAFLD is reversible. However, sustained oxidative distress induced by the continued accumulation of mH2O2 causing progressive cell damage and perturbed eustress leads to irreversible liver disease. The figure was generated with Biorender Software (Agreement number: KN25TFIEZ2).
Figure 3
Figure 3
Pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase (KGDH) as major mitochondrial (mH2O2) sources during reverse electron transfer (RET) from the ubiquinone pool. Under oxidative eustress conditions (left), electron flow from succinate, glycerol-3-phosphate, proline, and other sources generates NADH through proton return at complex I. Under these conditions, mitochondria are operating normally and the back fluxes in electrons are controlled. The NADH is then oxidized by PDH or KGDH (represented by the E1:E2:E3 subunits) and the electrons drive mH2O2 generation, which is transmitted into the cell to trigger proliferation and growth, cell adaptation, and tissue regeneration (e.g., in the case of liver recovery from injury). Oxidative distress (right) is triggered by mitochondrial dysfunction and metabolic gridlock. This can result in the accumulation of ubiquinone metabolites (e.g., succinate, glycerol-3-phosphate, proline), which drive the overgeneration of NADH by complex I through RET. This overloads PDH and KGDH with electrons resulting in the sustained overproduction of mH2O2. The resulting oxidative distress is related to the nonspecific and over-oxidation of protein cysteine thiols and the disruption of redox signaling circuits like protein S-glutathionylation (PSSG). The overgeneration of mH2O2 also triggers macromolecular damage and the induction of cell death. The figure was generated with Biorender Software (Agreement number: IC25TFIF36).
Figure 4
Figure 4
The protein S-glutathionylation cycle and the control of mH2O2production by PDH and KGDH through the reversible addition and removalof GSH to and from the E2 subunit.A, reversible protein S-glutathionylation (PSSG) occurs in response to changes in mH2O2 availability and the generation of NADPH, which drive reduced glutathione (GSH) pool oxidation to glutathione disulfide (GSSG) and its reduction through peroxidases and reductases. The decrease in the GSH/GSSG ratio activates the glutathionyltransferase activity of glutaredoxin-2 (Glrx2), resulting in the formation of PSSG. Reduction of the GSH pool and the increase in GSH/GSSG induces Glrx2 deglutathionylase activity restoring protein function. In this way, glutathionylation regulates proteins in response to changes in redox tone. Figure was generated using Biorender Software (Agreement number: YM25TFIF86). B, the dihydrolipoamide of the E2 subunit of PDH and KGDH is targeted for reversible glutathionylation. This increases and decreases mH2O2 generation in response to changes in redox tone, protecting cells from oxidative distress but also simultaneously modulating cell oxidative eustress signals. Figure was generated using Biorender Software (Agreement number: XE25TFIFB9).

Similar articles

Cited by

References

    1. Gallage S., Avila J.E.B., Ramadori P., Focaccia E., Rahbari M., Ali A., et al. A researcher's guide to preclinical mouse NASH models. Nat. Metab. 2022;4:1632–1649. - PubMed
    1. Carrieri L., Osella A.R., Ciccacci F., Giannelli G., Scavo M.P. Premenopausal syndrome and NAFLD: a new approach based on gender medicine. Biomedicines. 2022;10:1184. - PMC - PubMed
    1. Fromenty B., Roden M. Mitochondrial alterations in fatty liver diseases. J. Hepatol. 2023;78:415–429. - PubMed
    1. Karimkhanloo H., Keenan S.N., Bayliss J., De Nardo W., Miotto P.M., Devereux C.J., et al. Mouse strain-dependent variation in metabolic associated fatty liver disease (MAFLD): a comprehensive resource tool for pre-clinical studies. Sci. Rep. 2023;13:4711. - PMC - PubMed
    1. Grattagliano I., Di Ciaula A., Baj J., Molina-Molina E., Shanmugam H., Garruti G., et al. Protocols for mitochondria as the target of pharmacological therapy in the context of nonalcoholic fatty liver disease (NAFLD) Methods Mol. Biol. 2021;2310:201–246. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources